Your browser doesn't support javascript.
loading
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
Høland, Maren; Berg, Kaja C G; Eilertsen, Ina A; Bjerkehagen, Bodil; Kolberg, Matthias; Boye, Kjetil; Lingjærde, Ole Christian; Guren, Tormod K; Mandahl, Nils; van den Berg, Eva; Palmerini, Emanuela; Smeland, Sigbjørn; Picci, Piero; Mertens, Fredrik; Sveen, Anita; Lothe, Ragnhild A.
Afiliación
  • Høland M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • Berg KCG; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Eilertsen IA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Bjerkehagen B; Institute for Clinical Medicine, University of Oslo, Oslo, Norway; Division of Laboratory Medicine, Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Kolberg M; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Boye K; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Lingjærde OC; Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
  • Guren TK; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Mandahl N; Department of Clinical Genetics, University and Regional Laboratories, Lund University, Lund, Sweden.
  • van den Berg E; Department of Genetics, The University Medical Center Groningen, the Netherlands.
  • Palmerini E; Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Smeland S; Institute for Clinical Medicine, University of Oslo, Oslo, Norway; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Picci P; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Mertens F; Department of Clinical Genetics, University and Regional Laboratories, Lund University, Lund, Sweden.
  • Sveen A; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • Lothe RA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: rlothe@rr-research.no.
EBioMedicine ; 97: 104829, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37837931
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neurofibrosarcoma / Neoplasias de la Vaina del Nervio / Neurofibroma Límite: Adolescent / Adult / Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neurofibrosarcoma / Neoplasias de la Vaina del Nervio / Neurofibroma Límite: Adolescent / Adult / Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article País de afiliación: Noruega